Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Edwards Lifesciences Corp (EW) since 2015 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Edwards Lifesciences Corp. (See page 1 of this report.) Table 2 shows the detailed insider transactions. This company's CIK number is 1099800.
Total stock buying since 2015: $2,320,964.
Total stock sales since 2015: $955,812,098.
Total stock option exercises since 2015: $269,667,795.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2025 | 0 | $0 | 147,070 | $10,880,959 | 121,833 | $5,766,927 |
| 2024 | 580 | $49,730 | 436,617 | $36,821,216 | 443,141 | $15,365,052 |
| 2023 | 0 | $0 | 776,089 | $62,525,471 | 866,651 | $31,038,662 |
| 2022 | 0 | $0 | 722,684 | $73,906,699 | 972,597 | $23,063,224 |
| 2021 | 1,500 | $168,345 | 1,052,239 | $103,810,080 | 1,416,122 | $24,477,104 |
| 2020 | 0 | $0 | 1,262,598 | $128,977,831 | 1,566,127 | $30,035,920 |
| 2019 | 0 | $0 | 659,193 | $130,721,340 | 729,376 | $27,492,262 |
| 2018 | 0 | $0 | 888,652 | $124,048,601 | 871,925 | $32,595,505 |
| 2017 | 3,000 | $270,300 | 874,538 | $93,390,028 | 973,747 | $31,725,623 |
| 2016 | 20,870 | $1,832,589 | 1,079,098 | $105,613,525 | 1,213,936 | $28,166,951 |
| 2015 | 0 | $0 | 629,600 | $85,116,348 | 638,465 | $19,940,565 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2023-10-31 | Ullem Scott B. (CVP, Chief Financial Officer) | Sale | 7,255 | 62.66 | 454,569 |
| 2023-10-31 | Ullem Scott B. (CVP, Chief Financial Officer) | Option Ex | 7,255 | 36.75 | 266,621 |
| 2023-10-13 | Wood Larry L (Global President TAVR & Surg) | Sale | 8,660 | 69.94 | 605,663 |
| 2023-10-13 | Wood Larry L (Global President TAVR & Surg) | Option Ex | 8,660 | 45.28 | 392,098 |
| 2023-10-13 | Bobo Donald E Jr (CVP,Strategy/Corp Development) | Sale | 5,000 | 69.92 | 349,575 |
| 2023-10-13 | Bobo Donald E Jr (CVP,Strategy/Corp Development) | Option Ex | 5,000 | 36.75 | 183,750 |
| 2023-10-10 | Szyman Catherine M. (CVP, Critical Care) | Sale | 5,000 | 72.68 | 363,400 |
| 2023-10-10 | Szyman Catherine M. (CVP, Critical Care) | Option Ex | 5,000 | 36.75 | 183,750 |
| 2023-10-03 | Chopra Daveen (CVP, TMTT) | Sale | 17,000 | 70.00 | 1,190,000 |
| 2023-10-03 | Chopra Daveen (CVP, TMTT) | Option Ex | 17,000 | 59.26 | 1,007,368 |
| 2023-10-02 | Mussallem Michael A (Director) | Sale | 29,350 | 68.84 | 2,020,454 |
| 2023-10-02 | Mussallem Michael A (Director) | Option Ex | 29,350 | 36.75 | 1,078,612 |
| 2023-09-14 | Wood Larry L (Global President TAVR & Surg) | Sale | 8,660 | 73.63 | 637,618 |
| 2023-09-14 | Wood Larry L (Global President TAVR & Surg) | Option Ex | 8,660 | 45.28 | 392,098 |
| 2023-09-14 | Bobo Donald E Jr (CVP,Strategy/Corp Development) | Sale | 4,500 | 73.71 | 331,695 |
| 2023-09-14 | Bobo Donald E Jr (CVP,Strategy/Corp Development) | Option Ex | 4,500 | 36.75 | 165,375 |
| 2023-09-08 | Szyman Catherine M. (CVP, Critical Care) | Sale | 5,000 | 76.00 | 380,000 |
| 2023-09-08 | Szyman Catherine M. (CVP, Critical Care) | Option Ex | 5,000 | 36.75 | 183,750 |
| 2023-09-06 | Chopra Daveen (CVP, TMTT) | Sale | 8,500 | 76.07 | 646,612 |
| 2023-09-06 | Chopra Daveen (CVP, TMTT) | Option Ex | 8,500 | 59.26 | 503,684 |
| 2023-09-05 | Mussallem Michael A (Director) | Sale | 29,350 | 75.86 | 2,226,491 |
| 2023-09-05 | Mussallem Michael A (Director) | Option Ex | 29,350 | 36.75 | 1,078,612 |
| 2023-08-31 | Ullem Scott B. (CVP, Chief Financial Officer) | Sale | 7,255 | 77.79 | 564,366 |
| 2023-08-31 | Ullem Scott B. (CVP, Chief Financial Officer) | Option Ex | 7,255 | 36.75 | 266,621 |
| 2023-08-29 | Chopra Daveen (CVP, TMTT) | Sale | 1,500 | 76.69 | 115,041 |
| 2023-08-14 | Wood Larry L (Global President TAVR & Surg) | Sale | 6,421 | 79.30 | 509,185 |
| 2023-08-14 | Wood Larry L (Global President TAVR & Surg) | Option Ex | 6,421 | 45.28 | 290,723 |
| 2023-08-14 | Bobo Donald E Jr (CVP,Strategy/Corp Development) | Sale | 4,500 | 79.30 | 356,850 |
| 2023-08-14 | Bobo Donald E Jr (CVP,Strategy/Corp Development) | Option Ex | 4,500 | 36.75 | 165,375 |
| 2023-08-10 | Stone Heisz Leslie (Director) | Sale | 3,303 | 78.87 | 260,507 |
| 2023-08-09 | Szyman Catherine M. (CVP, Critical Care) | Sale | 5,000 | 78.64 | 393,185 |
| 2023-08-09 | Szyman Catherine M. (CVP, Critical Care) | Option Ex | 5,000 | 36.75 | 183,750 |
| 2023-08-07 | Mussallem Michael A (Director) | Sale | 29,350 | 80.20 | 2,353,870 |
| 2023-08-07 | Mussallem Michael A (Director) | Option Ex | 29,350 | 36.75 | 1,078,612 |
| 2023-07-31 | Ullem Scott B. (CVP, Chief Financial Officer) | Sale | 7,255 | 84.35 | 611,959 |
| 2023-07-31 | Ullem Scott B. (CVP, Chief Financial Officer) | Option Ex | 7,255 | 36.75 | 266,621 |
| 2023-07-14 | Wood Larry L (Global President TAVR & Surg) | Sale | 8,660 | 92.94 | 804,843 |
| 2023-07-14 | Wood Larry L (Global President TAVR & Surg) | Option Ex | 8,660 | 45.28 | 392,098 |
| 2023-07-14 | Bobo Donald E Jr (CVP,Strategy/Corp Development) | Sale | 3,500 | 92.94 | 325,276 |
| 2023-07-14 | Bobo Donald E Jr (CVP,Strategy/Corp Development) | Option Ex | 3,500 | 36.75 | 128,625 |
| 2023-07-10 | Szyman Catherine M. (CVP, Critical Care) | Sale | 5,000 | 90.52 | 452,600 |
| 2023-07-10 | Szyman Catherine M. (CVP, Critical Care) | Option Ex | 5,000 | 36.75 | 183,750 |
| 2023-07-05 | Mussallem Michael A (Director) | Sale | 29,350 | 90.92 | 2,668,648 |
| 2023-07-05 | Mussallem Michael A (Director) | Option Ex | 29,350 | 36.75 | 1,078,612 |
| 2023-06-30 | Ullem Scott B. (CVP, Chief Financial Officer) | Sale | 7,255 | 93.27 | 676,673 |
| 2023-06-30 | Ullem Scott B. (CVP, Chief Financial Officer) | Option Ex | 7,255 | 36.75 | 266,621 |
| 2023-06-14 | Wood Larry L (Global President TAVR & Surg) | Sale | 8,660 | 90.29 | 781,928 |
| 2023-06-14 | Wood Larry L (Global President TAVR & Surg) | Option Ex | 8,660 | 45.28 | 392,098 |
| 2023-06-14 | Bobo Donald E Jr (CVP,Strategy/Corp Development) | Sale | 3,500 | 89.77 | 314,195 |
| 2023-06-14 | Bobo Donald E Jr (CVP,Strategy/Corp Development) | Option Ex | 3,500 | 36.75 | 128,625 |
| 2023-06-13 | Szyman Catherine M. (CVP, Critical Care) | Sale | 5,000 | 85.81 | 429,045 |
| 2023-06-13 | Szyman Catherine M. (CVP, Critical Care) | Option Ex | 5,000 | 36.75 | 183,750 |
| 2023-06-01 | Mussallem Michael A (Director) | Sale | 29,350 | 84.36 | 2,475,966 |
| 2023-06-01 | Mussallem Michael A (Director) | Option Ex | 29,350 | 36.75 | 1,078,612 |
| 2023-05-24 | Wood Larry L (Global President TAVR & Surg) | Sale | 6,421 | 84.23 | 540,840 |
| 2023-05-24 | Wood Larry L (Global President TAVR & Surg) | Option Ex | 6,421 | 45.28 | 290,723 |
| 2023-05-10 | Ullem Scott B. (CVP, Chief Financial Officer) | Sale | 80,700 | 88.79 | 7,165,433 |
| 2023-05-10 | Ullem Scott B. (CVP, Chief Financial Officer) | Option Ex | 80,700 | 35.20 | 2,840,397 |
| 2023-05-10 | Mussallem Michael A (Chairman & CEO) | Sale | 19,875 | 88.61 | 1,761,223 |
| 2023-05-10 | Mussallem Michael A (Chairman & CEO) | Option Ex | 29,375 | 35.20 | 1,033,911 |
| 2023-05-10 | Bobo Donald E Jr (CVP,Strategy/Corp Development) | Sale | 2,500 | 89.22 | 223,050 |
| 2023-05-10 | Bobo Donald E Jr (CVP,Strategy/Corp Development) | Option Ex | 2,500 | 36.75 | 91,875 |
| 2023-05-09 | Lemercier Jean-luc M (CVP, EMEACLA and JAPAC) | Sale | 6,640 | 88.68 | 588,835 |
| 2023-05-09 | Lemercier Jean-luc M (CVP, EMEACLA and JAPAC) | Option Ex | 6,640 | 35.20 | 233,708 |
| 2023-05-09 | Szyman Catherine M. (CVP, Critical Care) | Sale | 75,600 | 88.94 | 6,724,241 |
| 2023-05-09 | Szyman Catherine M. (CVP, Critical Care) | Option Ex | 75,600 | 35.20 | 2,660,893 |
| 2023-05-07 | Chopra Daveen (CVP, TMTT) | Option Ex | 3,413 | .00 | 0 |
| 2023-05-07 | Lemercier Jean-luc M (CVP, EMEACLA and JAPAC) | Option Ex | 3,355 | .00 | 0 |
| 2023-05-07 | Zovighian Bernard J (President) | Option Ex | 5,003 | .00 | 0 |
| 2023-05-07 | Ullem Scott B. (CVP, Chief Financial Officer) | Option Ex | 6,062 | .00 | 0 |
| 2023-05-07 | Wood Larry L (CVP & Grp President TAVR & SSH) | Option Ex | 5,415 | .00 | 0 |
| 2023-05-07 | Szyman Catherine M. (CVP, Critical Care) | Option Ex | 4,708 | .00 | 0 |
| 2023-05-07 | Mussallem Michael A (Chairman & CEO) | Option Ex | 20,777 | .00 | 0 |
| 2023-05-07 | Bobo Donald E Jr (CVP,Strategy/Corp Development) | Option Ex | 4,767 | .00 | 0 |
| 2023-05-05 | Bobo Donald E Jr (CVP,Strategy/Corp Development) | Sale | 5,635 | 88.62 | 499,401 |
| 2023-04-28 | Sellers Robert W.a. (SVP, Corporate Controller) | Sale | 12,270 | 87.20 | 1,069,944 |
| 2023-04-28 | Sellers Robert W.a. (SVP, Corporate Controller) | Option Ex | 12,270 | 35.20 | 431,867 |
| 2023-04-14 | Mussallem Michael A (Chairman & CEO) | Sale | 19,875 | 84.36 | 1,676,555 |
| 2023-04-14 | Mussallem Michael A (Chairman & CEO) | Option Ex | 29,375 | 35.20 | 1,033,911 |
| 2023-04-06 | Lemercier Jean-luc M (CVP, EMEACLA and JAPAC) | Sale | 6,640 | 83.10 | 551,764 |
| 2023-04-06 | Lemercier Jean-luc M (CVP, EMEACLA and JAPAC) | Option Ex | 6,640 | 35.20 | 233,708 |
| 2023-04-06 | Bobo Donald E Jr (CVP,Strategy/Corp Development) | Sale | 6,725 | 83.09 | 558,800 |
| 2023-04-06 | Bobo Donald E Jr (CVP,Strategy/Corp Development) | Option Ex | 6,725 | 35.20 | 236,699 |
| 2023-03-15 | Chopra Daveen (CVP, TMTT) | Sale | 4,435 | 77.47 | 343,561 |
| 2023-03-15 | Chopra Daveen (CVP, TMTT) | Option Ex | 4,435 | 45.28 | 200,803 |
| 2023-03-14 | Mussallem Michael A (Chairman & CEO) | Sale | 19,875 | 77.59 | 1,542,101 |
| 2023-03-14 | Mussallem Michael A (Chairman & CEO) | Option Ex | 29,375 | 35.20 | 1,033,911 |
| 2023-03-08 | Lemercier Jean-luc M (CVP, EMEACLA and JAPAC) | Sale | 6,640 | 77.19 | 512,554 |
| 2023-03-08 | Lemercier Jean-luc M (CVP, EMEACLA and JAPAC) | Option Ex | 6,640 | 35.20 | 233,708 |
| 2023-03-08 | Bobo Donald E Jr (CVP,Strategy/Corp Development) | Sale | 6,725 | 76.96 | 517,555 |
| 2023-03-08 | Bobo Donald E Jr (CVP,Strategy/Corp Development) | Option Ex | 6,725 | 35.20 | 236,699 |
| 2023-02-16 | Stone Heisz Leslie (Director) | Sale | 9,671 | 76.82 | 742,945 |
| 2023-02-16 | Stone Heisz Leslie (Director) | Option Ex | 9,671 | 35.68 | 345,032 |
| 2023-02-15 | Chopra Daveen (CVP, TMTT) | Sale | 4,000 | 76.01 | 304,040 |
| 2023-02-15 | Chopra Daveen (CVP, TMTT) | Option Ex | 4,000 | 45.28 | 181,108 |
| 2023-02-14 | Mussallem Michael A (Chairman & CEO) | Sale | 19,875 | 77.29 | 1,536,138 |
| 2023-02-14 | Mussallem Michael A (Chairman & CEO) | Option Ex | 29,375 | 35.20 | 1,033,911 |
| 2023-02-06 | Bobo Donald E Jr (CVP,Strategy/Corp Development) | Sale | 6,725 | 80.75 | 543,043 |
| 2023-02-06 | Bobo Donald E Jr (CVP,Strategy/Corp Development) | Option Ex | 6,725 | 35.20 | 236,699 |
| 2023-01-17 | Chopra Daveen (CVP, TMTT) | Sale | 8,000 | 78.00 | 624,000 |
| 2023-01-17 | Chopra Daveen (CVP, TMTT) | Option Ex | 8,000 | 45.28 | 362,216 |
| 2023-01-13 | Mussallem Michael A (Chairman & CEO) | Sale | 19,875 | 78.09 | 1,552,118 |
| 2023-01-13 | Mussallem Michael A (Chairman & CEO) | Option Ex | 29,375 | 35.20 | 1,033,911 |
| 2023-01-09 | Bobo Donald E Jr (CVP,Strategy/Corp Development) | Sale | 6,725 | 77.50 | 521,187 |
| 2023-01-09 | Bobo Donald E Jr (CVP,Strategy/Corp Development) | Option Ex | 6,725 | 35.20 | 236,699 |
| 2022-12-15 | Chopra Daveen (CVP, Surgical Structural Heart) | Sale | 4,000 | 74.80 | 299,200 |
| 2022-12-15 | Chopra Daveen (CVP, Surgical Structural Heart) | Option Ex | 4,000 | 45.28 | 181,108 |
| 2022-12-14 | Mussallem Michael A (Chairman & CEO) | Sale | 19,875 | 76.83 | 1,526,936 |
| 2022-12-14 | Mussallem Michael A (Chairman & CEO) | Option Ex | 29,375 | 35.20 | 1,033,911 |
| 2022-12-12 | Bobo Donald E Jr (CVP,Strategy/Corp Development) | Sale | 6,725 | 74.32 | 499,801 |
| 2022-12-12 | Bobo Donald E Jr (CVP,Strategy/Corp Development) | Option Ex | 6,725 | 35.20 | 236,699 |
| 2022-11-14 | Mussallem Michael A (Chairman & CEO) | Sale | 19,875 | 74.76 | 1,485,795 |
| 2022-11-14 | Mussallem Michael A (Chairman & CEO) | Option Ex | 29,375 | 35.20 | 1,033,911 |
| 2022-10-14 | Chopra Daveen (CVP, Surgical Structural Heart) | Sale | 4,000 | 84.77 | 339,080 |
| 2022-10-14 | Chopra Daveen (CVP, Surgical Structural Heart) | Option Ex | 4,000 | 45.28 | 181,108 |
| 2022-10-14 | Mussallem Michael A (Chairman & CEO) | Sale | 19,875 | 83.93 | 1,668,069 |
| 2022-10-14 | Mussallem Michael A (Chairman & CEO) | Option Ex | 29,375 | 35.20 | 1,033,911 |
| 2022-10-11 | Wood Larry L (CVP, TAVR) | Sale | 7,242 | 82.12 | 594,713 |
| 2022-10-11 | Wood Larry L (CVP, TAVR) | Option Ex | 7,242 | 36.75 | 266,143 |
| 2022-10-10 | Bobo Donald E Jr (CVP,Strategy/Corp Development) | Sale | 6,725 | 85.00 | 571,625 |
| 2022-10-10 | Bobo Donald E Jr (CVP,Strategy/Corp Development) | Option Ex | 6,725 | 35.20 | 236,699 |
| 2022-09-22 | Mussallem Michael A (Chairman & CEO) | Sale | 19,875 | 84.66 | 1,682,657 |
| 2022-09-22 | Mussallem Michael A (Chairman & CEO) | Option Ex | 29,375 | 35.20 | 1,033,911 |
| 2022-09-08 | Bobo Donald E Jr (CVP,Strategy/Corp Development) | Sale | 13,450 | 90.94 | 1,223,142 |
| 2022-09-08 | Bobo Donald E Jr (CVP,Strategy/Corp Development) | Option Ex | 13,450 | 35.20 | 473,398 |
| 2022-09-06 | Wood Larry L (CVP, TAVR) | Sale | 7,242 | 89.00 | 644,538 |
| 2022-09-06 | Wood Larry L (CVP, TAVR) | Option Ex | 7,242 | 36.75 | 266,143 |
| 2022-08-15 | Mussallem Michael A (Chairman & CEO) | Sale | 19,875 | 104.79 | 2,082,641 |
| 2022-08-15 | Mussallem Michael A (Chairman & CEO) | Option Ex | 29,375 | 35.20 | 1,033,911 |
| 2022-08-09 | Wood Larry L (CVP, TAVR) | Sale | 7,242 | 104.81 | 759,048 |
| 2022-08-09 | Wood Larry L (CVP, TAVR) | Option Ex | 7,242 | 36.75 | 266,143 |
| 2022-08-09 | Bobo Donald E Jr (CVP,Strategy/Corp Development) | Sale | 6,725 | 105.01 | 706,192 |
| 2022-08-09 | Bobo Donald E Jr (CVP,Strategy/Corp Development) | Option Ex | 6,725 | 35.20 | 236,699 |
| 2022-08-05 | Zovighian Bernard J (CVP, TMTT) | Sale | 4,811 | 103.66 | 498,708 |
| 2022-08-02 | Chopra Daveen (CVP, Surgical Structural Heart) | Sale | 1,000 | 102.49 | 102,490 |
| 2022-07-14 | Mussallem Michael A (Chairman & CEO) | Sale | 19,875 | 95.77 | 1,903,488 |
| 2022-07-14 | Mussallem Michael A (Chairman & CEO) | Option Ex | 29,375 | 35.20 | 1,033,911 |
| 2022-07-08 | Wang Huimin (CVP, Japan & Intercontinental) | Sale | 3,675 | 97.60 | 358,680 |
| 2022-07-08 | Wang Huimin (CVP, Japan & Intercontinental) | Option Ex | 3,675 | 35.20 | 129,348 |
| 2022-07-08 | Bobo Donald E Jr (CVP,Strategy/Corp Development) | Sale | 6,725 | 97.60 | 656,360 |
| 2022-07-08 | Bobo Donald E Jr (CVP,Strategy/Corp Development) | Option Ex | 6,725 | 35.20 | 236,699 |
| 2022-07-05 | Wood Larry L (CVP, TAVR) | Sale | 7,242 | 95.90 | 694,486 |
| 2022-07-05 | Wood Larry L (CVP, TAVR) | Option Ex | 7,242 | 36.75 | 266,143 |
| 2022-06-14 | Zovighian Bernard J (CVP, TMTT) | Sale | 4,809 | 87.75 | 421,989 |
| 2022-06-14 | Wang Huimin (CVP, Japan & Intercontinental) | Sale | 3,675 | 87.75 | 322,481 |
| 2022-06-14 | Wang Huimin (CVP, Japan & Intercontinental) | Option Ex | 3,675 | 35.20 | 129,348 |
| 2022-06-14 | Mussallem Michael A (Chairman & CEO) | Sale | 19,875 | 87.10 | 1,731,112 |
| 2022-06-14 | Mussallem Michael A (Chairman & CEO) | Option Ex | 29,375 | 35.20 | 1,033,911 |
| 2022-06-13 | Bobo Donald E Jr (CVP,Strategy/Corp Development) | Sale | 6,725 | 90.21 | 606,689 |
| 2022-06-13 | Bobo Donald E Jr (CVP,Strategy/Corp Development) | Option Ex | 6,725 | 35.20 | 236,699 |
Insider trading activities including stock purchases, stock sales, and option exercises of EW listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Edwards Lifesciences Corp (symbol EW, CIK number 1099800) see the Securities and Exchange Commission (SEC) website.